Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR booster vaccination in juvenile idiopathic arthritis
2007-001861-14Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2008
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of M-M-R II in juvenile idiopathic arthritis (JIA), measles, mumps and 1 more (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Safety of MMR booster vaccination. Started Feb 2008; status: active.
02
Drugs
M-M-R II
03
Conditions
juvenile idiopathic arthritis (JIA)measlesmumpsrubella
Beyond the preview
Go deeper on 2007-001861-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001861-14.